5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine(CAS: 875781-18-3)

Regulatory guidelines applicable to 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine (CAS: 875781-18-3) include the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for European manufacturers and importers, and FDA and EPA requirements in the United States. These guidelines ensure proper handling, storage, and disposal of the compound, as well as its safe transportation and environmental protection.

While 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine (CAS: 875781-18-3) is a specific compound, alternatives in synthesis include using 5-bromo-3-iodopyrazolo[3,4-b]pyridine analogs, isomers, or other related compounds. Common alternative reagents include bromo-iodopyrazoles, which can serve similar functional group transformations in organic synthesis.

The market trend for 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine (CAS: 875781-18-3) reflects increasing interest in its use as a key intermediate in the development of antiviral agents and other pharmaceuticals. Research trends are shifting towards more sustainable and environmentally friendly synthesis methods, as well as the exploration of its potential in medicinal chemistry and drug discovery.

Waste containing 5-Bromo-3-iodo-1H-pyrazolo[3,4-b]pyridine (CAS: 875781-18-3) should be collected in designated containers and disposed of through incineration or professionally managed waste disposal services, in compliance with local and international environmental regulations. Proper precautions include ensuring the waste is labeled and segregated to prevent environmental contamination and health risks.